BridgeMD
Tests treatment safety and results for Gingivitis
Official title Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis
ClinicalTrials.gov ID: NCT07270705
What this study is testing
- What it's testing
- Gingivitis is a reversible inflammation of the gums caused by the accumulation of dental plaque. Without appropriate intervention-such as proper oral hygiene and plaque removal-gingivitis can progress to periodontitis, leading to clinical attachment loss, alveolar bone resorption, and ultimately tooth loss.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Systemically healthy participants aged 18 years or older.
- Presence of at least 20 natural teeth.
- Probing pocket depth less than or equal to 3 mm.
- Presence of bleeding on probing in more than 10% of sites.
- Mean Gingival Index (Silness \& Löe) of at least 1.
You likely can't join if
- Periodontal treatment within the last three months.
- Diagnosis of periodontitis.
- Use of mouth rinses or oral gels within the last month.
- Use of antibiotic therapy within the last three months.
- Known allergy or hypersensitivity to any components of the investigational products.
- Ongoing treatment with antihypertensive, antilipemic, antiarrhythmic, or other cardiovascular medications.
See the full eligibility criteria
- Systemically healthy participants aged 18 years or older.
- Presence of at least 20 natural teeth.
- Probing pocket depth less than or equal to 3 mm.
- Presence of bleeding on probing in more than 10% of sites.
- Mean Gingival Index (Silness \& Löe) of at least 1.
- Ability and willingness to follow oral hygiene instructions after the intervention.
- Signed informed consent form after being informed about the study.
- Periodontal treatment within the last three months.
- Diagnosis of periodontitis.
- Use of mouth rinses or oral gels within the last month.
- Use of antibiotic therapy within the last three months.
- Known allergy or hypersensitivity to any components of the investigational products.
- Ongoing treatment with antihypertensive, antilipemic, antiarrhythmic, or other cardiovascular medications.
- Presence of systemic diseases such as diabetes, HIV/AIDS, liver disease, chronic kidney disease, tuberculosis, or autoimmune disorders (e.g., lupus, scleroderma, Crohn's disease).
- Use of immunosuppressive medications.
- Ongoing orthodontic treatment, fixed orthodontic appliance, or removable denture.
- Pregnant or breastfeeding women.
- Smokers.
The study team makes the final eligibility decision.
Where it's taking place
- Ljubljana, Slovenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ljubljana, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.